ImmunityBio’s hAd5 vaccine candidate for Covid-19 succeeds in preclinical study
The hAd5 vaccine, which contains the spike (S) and also the nucleocapsid (N) SARS-CoV-2 proteins (hAd5 S + N), delivered strong T cell and humoral immune responses against